The Business of Business

expiated said:
I began posting entries here at EliteTrader somewhere around August of 2018 and found this practice to be invaluable in that it helped me further develop a Forex day trading system until I eventually had enough material to begin relating the approach in explicit terms in my own private notes, which I think I have subsequently refined to the point that losing money using its methodology is virtually impossible.

This has freed me up to turn my attention to other interests, among which are business and finance. My thought is that perhaps I can take advantage of this online repository of thoughts and ideas with respect to commercial enterprise in much the same way as I did concerning the buying and selling of foreign currency pairs. Since I saw no specific ET category for Business and Finance, I will be approaching this subject as a hobby.

Personally, my preference when it comes to self-education is to use a mastery learning approach in which I do not introduce any new material until I have memorized the information already covered. Accordingly, I am only going to take on a little bit of substance at a time.

Given past questions I've had about market valuation, I going to begin here by memorizing that: "A good valuation of a company takes into account certain factors, such as…"
  1. Present value
  2. Future value
  3. Value of similar companies
  4. Risk
I recently explored some intriguing b2b business ideas on Global Sources and found a few that stand out. One idea is leveraging data analytics to offer actionable insights to small businesses, helping them optimize their operations. Another is providing specialized consulting services for emerging markets, where local expertise is scarce. Additionally, developing a platform that connects suppliers with manufacturers can streamline the procurement process and reduce costs. Each of these ideas taps into current market needs and could be a great starting point for a B2B venture. I'd love to hear if anyone has tried these or has other innovative suggestions!
More...

Based on my experience with B2B business ideas, focusing on niche markets and leveraging technology has been game-changing. I launched a platform that connects small suppliers with larger manufacturers, which has significantly streamlined procurement processes. By honing in on specific needs and using tech solutions, I've seen impressive growth and efficiency in my operations.
 
San Francisco's only Denny's restaurant has permanently closed after more than two decades in operation, according to reports. The business, which was one of the few 24-hour restaurants left in the city, closed this month at 816 Mission St., according to SFGATE.

~ San Francisco Chronicle

The last remaining Denny's in San Francisco closed earlier this month after nearly 25 years of operation. The closure was primarily due to several challenges, including:
It's a tough situation for the community and the employees who worked there. Is there anything else you’d like to know about this or any other topic?

(I have little doubt this has much to do with liberal policies on crime, drug use, homelessness, wages, taxes and compliance regulations.)
 
Yet another reason to hold a negative view of the Walt Disney Corporation...
Screenshot_7.png


 
Who are the 15 people in the world who are worth more than $100 billion?

As of now, the elite group of people worth more than $100 billion includes some of the most well-known names in business and technology. Here are the 15 individuals who are part of this exclusive club:
  1. Elon Musk - CEO of Tesla and SpaceX, with a net worth of $245 billion.
  2. Jeff Bezos - Founder and executive chairman of Amazon, worth $201 billion.
  3. Bernard Arnault - CEO of LVMH, with a net worth of $197 billion.
  4. Mark Zuckerberg - CEO of Meta (formerly Facebook), worth $114 billion.
  5. Bill Gates - Co-founder of Microsoft, with a net worth of $113 billion.
  6. Larry Ellison - Co-founder of Oracle, worth $112 billion.
  7. Warren Buffett - CEO of Berkshire Hathaway, with a net worth of $110 billion.
  8. Larry Page - Co-founder of Google, worth $109 billion.
  9. Sergey Brin - Co-founder of Google, with a net worth of $107 billion.
  10. Steve Ballmer - Former CEO of Microsoft, worth $106 billion.
  11. Michael Dell - Founder of Dell Technologies, with a net worth of $112 billion.
  12. Carlos Slim - Mexican businessman, worth $106 billion.
  13. Françoise Bettencourt Meyers - Heiress to L’Oréal, with a net worth of $101 billion.
  14. Mukesh Ambani - Chairman of Reliance Industries, worth $100 billion.
  15. Gautam Adani - Chairman of Adani Group, with a net worth of $100 billion2.
These individuals have amassed their fortunes through various industries, including technology, retail, and luxury goods. Their combined wealth is staggering, reflecting their significant influence on the global economy.
 
What are the serious heath risks for children posed by the magnetic chess game sold at Walmart?

The magnetic chess game sold at Walmart (the "Kidbro Magnetic Chess Game," sold by Newish Trade Inc.) presents serious health risks to children primarily due to the ingestion of loose and hazardous magnets. These risks can lead to severe injuries or even death.

Ingestion Risks

The magnetic chess game contains loose, hazardous magnets that pose significant risks of serious injury or death if swallowed by children. Once ingested, these magnets can attract to one another or to other metal objects within the digestive system, which can cause various complications. This situation highlights the critical dangers involved in the use of such magnetic toys among children.

Severe Health Complications

If swallowed, the magnets can become lodged in the digestive tract, leading to perforations, blockages, or twisting of the intestines. This may result in severe medical conditions such as infection, blood poisoning, and potentially fatal outcomes. According to the Consumer Product Safety Commission (CPSC), there have been reported instances where magnet ingestions led to death, underscoring the hazards involved.

Regulatory Non-Compliance

Additionally, the CPSC has highlighted that the magnets in this chess game do not meet federal safety regulations. This violation arises because the magnets do not fit within the safety standards [regarding size] for small parts, increasing the likelihood of ingestion. The presence of strong magnets in toys designed for children also raises alarm about their safety and compliance with regulatory standards.

Urgency for Action

The CPSC has urged consumers to stop using these magnetic chess games immediately, take them away from children, and appropriately dispose of them. This recommendation reflects the urgent need to mitigate risk and protect children from these hazardous products.

By understanding these serious health risks, parents and caregivers can take proactive measures to prevent incidents related to hazardous magnetic toys.
 
Screenshot_7.png


Whatever became of the XPL cross-linked polymer wrinkle reduction gel that Bob Langer, MIT scientists and Olivo Laboratories were working on in 1916, as published online May 9th in Nature Materials?

The XPL (cross-linked polymer) technology, initially developed by MIT scientists, including Bob Langer, along with Olivo Laboratories, has transitioned towards commercial applications. Since its development in 2016, the technology has evolved from being primarily a research project into practical solutions for both cosmetic and medical purposes.

1. Development and Purpose
The XPL technology was designed to create a silicone-based polymer that can be applied as an invisible layer on the skin to temporarily reduce wrinkles and provide hydration. Researchers have noted that this material not only serves cosmetic purposes but is also capable of delivering treatments for various skin conditions such as eczema.

2. Method of Application
The application of the XPL is facilitated through a two-step process: first, the polysiloxane components are applied, followed by a platinum catalyst that forms a strong cross-linked film. This process allows the material to remain effective on the skin for up to 24 hours without any irritation reported from participants in clinical trials.

3. Commercialization
Following its development, the XPL technology was spun out to Olivo Laboratories, a startup formed to advance the practical applications of this technology. The team at Olivo Labs is focusing on both cosmetic and non-cosmetic applications, including the potential incorporation of antimicrobial agents.

4. Clinical and Cosmetic Impact
Studies conducted with the XPL indicated significant efficacy in water retention, outperforming high-end moisturizers in maintaining skin hydration over time. Its ability to mimic the properties of youthful skin has led to keen interest for various applications in dermatology and cosmetic enhancement.

5. Current Status
As of now, advancements continue to be made with the XPL technology for treating skin conditions and enhancing cosmetic results. There is ongoing potential for it to address a wide range of dermatological issues, reflecting its promise as a versatile material in both medical and cosmetic fields.

In conclusion, the XPL cross-linked polymer technology has successfully transitioned from initial research to a promising platform for both cosmetic and treatment applications, with ongoing developments at Olivo Laboratories.


What is the holdup keeping Olivo Laboratory's XPL cross-linked polymer "second skin" product from commercial release after eight years in development?

The commercial release of Olivo Laboratory's XPL cross-linked polymer "second skin" has faced several challenges, including regulatory hurdles, market adoption issues, and the complexities of integrating with larger corporate structures following its acquisition by Shiseido. These factors have contributed to delays in bringing the product to the market despite its promising developments.

1. Regulatory Hurdles
One of the significant challenges in the commercial release of the XPL product is overcoming regulatory roadblocks. Biopharma companies like Olivo face scrutiny regarding product safety and effectiveness, which can delay the approval process for new skincare technologies .

2. Market Adoption Issues
Market adoption presents another significant barrier. The successful launch of new products requires securing healthcare professional (HCP) engagement and consumer acceptance, which can be particularly difficult in a competitive landscape. This is compounded by the need for effective educational outreach about the new technology to demonstrate its advantages over existing options.

3. Acquisition Integration Challenges
The acquisition of Olivo Laboratories by Shiseido in 2018 has added layers of complexity to the product's development and release. Integration into Shiseido's larger corporate environment may have introduced additional bureaucratic processes and priorities that could potentially slow down development timelines .

4. Development Complexity
The technical aspects involved in creating a product like XPL contribute to its lengthy development timeline. This silicone-based polymer requires extensive testing and validation to ensure that it mimics the properties of healthy skin effectively without causing irritation. Additionally, the product's two-step application process must be optimized for ease of use and effectiveness.

5. Challenges in Project Management
Logistical challenges, including those related to inventory management and distribution, could also influence the timeline for commercialization. Effective collaboration with logistics providers and choosing appropriate transport and delivery methods are vital for getting such innovative products to market .

In summary, the holdup in the commercial release of Olivo Laboratory's XPL product is attributed to:
  • Regulatory challenges
  • Market acceptance
  • Corporate integration issues
  • Complexity of the product development
  • Logistical challenges.
The combination of these factors has significantly impacted the project timeline from its initiation to potential market debut.
 
You must log in or register to reply here.
Back
Top